Zobrazeno 1 - 10
of 189
pro vyhledávání: '"Joleen M, Hubbard"'
Autor:
Tara L. Hogenson, Hao Xie, William J. Phillips, Merih D. Toruner, Jenny J. Li, Isaac P. Horn, Devin J. Kennedy, Luciana L. Almada, David L. Marks, Ryan M. Carr, Murat Toruner, Ashley N. Sigafoos, Amanda N. Koenig-Kappes, Rachel L.O. Olson, Ezequiel J. Tolosa, Cheng Zhang, Hu Li, Jason D. Doles, Jonathan Bleeker, Michael T. Barrett, James H. Boyum, Benjamin R. Kipp, Amit Mahipal, Joleen M. Hubbard, Temperance J. Scheffler Hanson, Gloria M. Petersen, Surendra Dasari, Ann L. Oberg, Mark J. Truty, Rondell P. Graham, Michael J. Levy, Mojun Zhu, Daniel D. Billadeau, Alex A. Adjei, Nelson Dusetti, Juan L. Iovanna, Tanios S. Bekaii-Saab, Wen Wee Ma, Martin E. Fernandez-Zapico
Publikováno v:
JCI Insight, Vol 7, Iss 22 (2022)
BACKGROUND A patient-derived organoid (PDO) platform may serve as a promising tool for translational cancer research. In this study, we evaluated PDO’s ability to predict clinical response to gastrointestinal (GI) cancers.METHODS We generated PDOs
Externí odkaz:
https://doaj.org/article/f973dfbdbe53458f81a1c8da0742e768
Autor:
Krishan R. Jethwa, Courtney N. Day, Harigopal Sandhyavenu, Karthik Gonuguntla, William S. Harmsen, William G. Breen, David M. Routman, Allison E. Garda, Joleen M. Hubbard, Thorvardur R. Halfdanarson, Michelle A. Neben-Wittich, Kenneth W. Merrell, Christopher L. Hallemeier, Michael G. Haddock
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 28, Iss , Pp 17-23 (2021)
Introduction: To report long-term efficacy and adverse events (AEs) associated with intensity modulated radiotherapy (IMRT) for patients with anal canal squamous cell carcinoma (ASCC). Materials and methods: This was a retrospective review of patient
Externí odkaz:
https://doaj.org/article/f80ea376971d4cb7a9c61ec994194be0
Autor:
John H Strickler, Andrea Cercek, Salvatore Siena, Thierry André, Kimmie Ng, Eric Van Cutsem, Christina Wu, Andrew S Paulson, Joleen M Hubbard, Andrew L Coveler, Christos Fountzilas, Adel Kardosh, Pashtoon M Kasi, Heinz-Josef Lenz, Kristen K Ciombor, Elena Elez, David L Bajor, Chiara Cremolini, Federico Sanchez, Michael Stecher, Wentao Feng, Tanios S Bekaii-Saab, Marc Peeters, Marc Van den Evnde, Christophe Borg, Matthieu Sarabi, Francois Ghiringhelli, Benoist Chibaudel, Maria G. Zampino, Susana R. Keranen, Ramon Salazar, Pilar Alfonso, John H. Strickler, Andrew S. Paulson, Joleen M. Hubbard, Andrew L. Coveler, Pashtoon M. Kasi, Kristen K. Ciombor, David L. Bajor, Tanios S. Bekaii-Saab, Olumide Gbolahan, Patrick Boland, Daniel Berg, Timothy Goggins, Anwar Saeed, Howard Burris, Johanna Bendell, Darryl Outlaw, Isaac Tafur, Ardaman Shergill, Daniel Catenacci, Jun Gong, Ignacio Garrido-Laguna, Gene Finley, Benjamin Weinberg, Anthony Shields, Philip Philip, Anita Turk, Anthony Nguyen, Fadi Braiteh, Vijay Patel, William Harwin, Ian Anderson, Ajay Kundra, Christopher Chen, James Ford, Madappa Kundranda, Danny Nguyen, Suresh Ratnam, Donald Richards, Sujatha Nallapareddy, Sridhar Beeram, Scott McKenney, Spencer Shao
Publikováno v:
The Lancet Oncology. 24:496-508
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7adfd2ad44d4d2c2a9c7ef887cf177ac
https://doi.org/10.1016/s1470-2045(23)00150-x
https://doi.org/10.1016/s1470-2045(23)00150-x
Autor:
Edoardo Francini, Fang-Shu Ou, Stefano Lazzi, Roberto Petrioli, Andrea G. Multari, Guido Pesola, Luciana Messuti, Elena Colombo, Virginia Livellara, Serena Bazzurri, Sara Cherri, Salvatora T. Miano, Eric G. Wolfe, Steven R. Alberts, Joleen M. Hubbard, Harry H. Yoon, Guido Francini
Publikováno v:
Translational Oncology, Vol 14, Iss 2, Pp 100973- (2021)
Background: High tumor infiltrating lymphocytes (TILs) density was previously shown to be associated with favorable prognosis for patients with colon cancer (CC). However, the impact of TILs on overall survival (OS) of stage II CC patients who receiv
Externí odkaz:
https://doaj.org/article/bb727b9e9ca8480e8ece3bee7ce744b5
Autor:
Meena Okera, Brian A. Van Tine, Joleen M. Hubbard, Minal Barve, Erika Hamilton, Monica M. Mita, Frances Valdes-Albini, Daniel Ahn, Admasu Mamuye, Joshua Pelham, Amy Yuet, Diana Yurewicz, Yanning Liu, Andres Machado Sandri, William J. Edenfield, Aki Morikawa, William Gradishar, Rajiv Kumar, Zev A. Wainberg
Publikováno v:
Cancer Research. 83:OT2-11
MT-5111 is a 55kD engineered toxin body targeting HER2 in solid tumors that binds to an epitope distinct from trastuzumab and pertuzumab, offering potential combination strategies with other HER2-targeting agents. MT-5111 works by internalizing, self
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::371f690d9bd1864fa82d1608053510e3
https://doi.org/10.1158/1538-7445.sabcs22-ot2-11-01
https://doi.org/10.1158/1538-7445.sabcs22-ot2-11-01
Autor:
Hao Xie, Jacqueline M. Lafky, Bruce W. Morlan, Philip J. Stella, Shaker R. Dakhil, Gerald G. Gross, William S. Loui, Joleen M. Hubbard, Steven R. Alberts, Axel Grothey
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: Bevacizumab (BEV), a monoclonal antibody against vascular endothelial growth factor-A (VEGF-A), is a standard component of medical therapy of metastatic colorectal cancer (mCRC). Activation of alternative angiogenesis pathways has been im
Externí odkaz:
https://doaj.org/article/a68f44c6d5e44ed1866977c2a7898ead
Autor:
Matthew H. G. Katz, Fang-Shu Ou, Joseph M. Herman, Syed A. Ahmad, Brian Wolpin, Robert Marsh, Spencer Behr, Qian Shi, Michael Chuong, Lawrence H. Schwartz, Wendy Frankel, Eric Collisson, Eugene J. Koay, JoLeen M. Hubbard, James L. Leenstra, Jeffrey Meyerhardt, Eileen O’Reilly, for the Alliance for Clinical Trials on Oncology
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-8 (2017)
Abstract Background Borderline resectable pancreatic cancers infiltrate into adjacent vascular structures to an extent that makes an R0 resection unlikely when pancreatectomy is performed de novo. In a pilot study, Alliance for Clinical Trials in Onc
Externí odkaz:
https://doaj.org/article/309dcfbae6bc4c4bbb5d12861352a1a3
Autor:
Haddock, Elizabeth B. Jeans, Daniel K. Ebner, Hirotoshi Takiyama, Kaitlin Qualls, Danielle A. Cunningham, Mark R. Waddle, Krishan R. Jethwa, William S. Harmsen, Joleen M. Hubbard, Eric J. Dozois, Kellie L. Mathis, Hiroshi Tsuji, Kenneth W. Merrell, Christopher L. Hallemeier, Anita Mahajan, Shigeru Yamada, Robert L. Foote, Michael G.
Publikováno v:
Cancers; Volume 15; Issue 11; Pages: 3057
No standard treatment paradigm exists for previously irradiated locally recurrent rectal cancer (PILRRC). Carbon-ion radiotherapy (CIRT) may improve oncologic outcomes and reduce toxicity compared with combined modality therapy (CMT). Eighty-five pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::86cb234f7125aaaa53624d741010fe06
Autor:
Kari G. Rabe, Maria A. Stevens, Amanda Toledo Hernández, Shruti Chandra, Joleen M. Hubbard, Jennifer L. Kemppainen, Shounak Majumder, Gloria M. Petersen
Publikováno v:
Genet Med
Pancreatic cancer (PC) risk is increased in families, but PC risk and risk perception have been understudied when both parents have cancer.An unbiased method defining cancer triads (proband with PC and both parents with cancer) in a prospective regis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b29edaa69dc5275753fee270a6c024c4
https://doi.org/10.1016/j.gim.2022.01.016
https://doi.org/10.1016/j.gim.2022.01.016
Autor:
John B. Kisiel, David A. Ahlquist, Graham P. Lidgard, Michael W. Kaiser, Hatim T. Allawi, Joleen M. Hubbard, Tsung-Teh Wu, Calise K. Berger, Maria McGlinch, Xiaoming Cao, Sara S. Then, William R. Taylor, Karen A. Doering, Kelli N. Burger, Patrick H. Foote, Douglas W. Mahoney, Hao Xie
Supplemental Table 1 Baseline characteristics of patients in Primary and Metastatic Tissue MDM Concordance Study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e6140eadd916a8d5b2bed2b2dd65a56
https://doi.org/10.1158/1078-0432.22478361.v1
https://doi.org/10.1158/1078-0432.22478361.v1
